Does hyperpolarized MR using [1-13C]pyruvate provide a method for the assessment of innate immune cell-driven inflammation in the heart after MI?
Hyperpolarized MR with [1-13C]pyruvate represents a novel, noninvasive imaging modality for assessing cardiac inflammation post-MI with potential for clinical translation.
Hyperpolarized MR using 1-13Cpyruvate provides a novel method for the assessment of innate immune cell-driven inflammation in the heart after MI, with broad potential applicability across other cardiovascular disease states and suitability for early clinical translation.
Lewis et al. (Mon,) studied this question.